Executive Vice President, Commercial International
In it to help cancer patients worldwide have access to our innovative medicines.
Tuomo joined us in June 2020 to lead our new Commercial organization in Europe, Canada and rest of world outside the U.S. He brings deep international commercial expertise with broad experience in scaling up commercial teams and launching multiple oncology drugs. Tuomo brings extensive commercial leadership experience from Celgene, Human Genome Sciences, and Amgen. Most recently at Celgene, Tuomo was President, Worldwide Markets where he had responsibility for their ex-U.S. hematology/oncology business.
Tuomo holds a M. Sc. from the Helsinki University School of Pharmacy.
You are leaving Seagen
You are now leaving Seagen site. Seagen does not necessarily endorse the organization associated with this link and takes no responsibility for the content contained therein. This resource link is for informational purposes only. Do you want to continue to the external site and leave Seagen.com?